Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China
· Delayed Price · Currency is CNY 26.02
+0.08 (0.31%)
At close: Jun 11, 2025, 2:57 PM CST
SHA:688739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 333.58 | 342.82 | 465.92 | 714.02 | 892.49 | 918.19 | Upgrade
|
| Depreciation & Amortization | 169.7 | 169.7 | 125.27 | 121.22 | 116.1 | 64.84 | Upgrade
|
| Other Amortization | 6.3 | 6.3 | 3.71 | 2.22 | 1.32 | 0.64 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.09 | -0.09 | -2.48 | -0.04 | -0.01 | -0.13 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.8 | 1.8 | 0.87 | 0.83 | 0.71 | 23.78 | Upgrade
|
| Loss (Gain) From Sale of Investments | 60.02 | 60.02 | 20.27 | -27.25 | -14.2 | -89.21 | Upgrade
|
| Provision & Write-off of Bad Debts | 8.66 | 8.66 | 12.77 | 15.08 | 16.44 | -6.26 | Upgrade
|
| Other Operating Activities | 47.69 | 33.21 | 55.43 | 7.98 | 8.11 | 4.29 | Upgrade
|
| Change in Accounts Receivable | -18.02 | -18.02 | 13.82 | -156.41 | -436.49 | -31.05 | Upgrade
|
| Change in Inventory | -73.27 | -73.27 | 0.42 | -104.11 | -109.74 | -31.42 | Upgrade
|
| Change in Accounts Payable | -27.59 | -27.59 | -11.84 | -17.55 | 45.15 | -0.18 | Upgrade
|
| Change in Other Net Operating Assets | 0.06 | 0.06 | 0.06 | 0.08 | 0.1 | -0.61 | Upgrade
|
| Operating Cash Flow | 506.2 | 500.96 | 677.01 | 546.49 | 506.38 | 859.55 | Upgrade
|
| Operating Cash Flow Growth | -15.87% | -26.00% | 23.88% | 7.92% | -41.09% | 18.74% | Upgrade
|
| Capital Expenditures | -345.95 | -362.48 | -551.99 | -511.61 | -508.35 | -188.2 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.92 | 10.98 | 0.02 | 0.15 | 0.02 | 0.21 | Upgrade
|
| Cash Acquisitions | -0.06 | -0.06 | -0.06 | -0.08 | -0.09 | - | Upgrade
|
| Investment in Securities | -455.27 | 156.81 | -883.2 | 3,327 | -2,598 | -733.15 | Upgrade
|
| Other Investing Activities | 32.62 | 31.92 | 32.95 | 75.04 | 40.72 | 38.94 | Upgrade
|
| Investing Cash Flow | -763.73 | -162.83 | -1,402 | 2,890 | -3,066 | -882.2 | Upgrade
|
| Long-Term Debt Repaid | - | -5.85 | -6.38 | -5.41 | -5.63 | - | Upgrade
|
| Net Debt Issued (Repaid) | -5.85 | -5.85 | -6.38 | -5.41 | -5.63 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 4,371 | - | Upgrade
|
| Repurchase of Common Stock | -50 | -50 | -99.99 | - | - | - | Upgrade
|
| Common Dividends Paid | -329.38 | -329.38 | -416.32 | -416.3 | - | -224.88 | Upgrade
|
| Dividends Paid | -329.38 | -329.38 | -416.32 | -416.3 | - | -224.88 | Upgrade
|
| Other Financing Activities | 16.97 | - | - | - | -18.95 | -11 | Upgrade
|
| Financing Cash Flow | -368.27 | -385.23 | -522.69 | -421.7 | 4,347 | -235.88 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.97 | 0.55 | 2.29 | 1.58 | -0.36 | -1.05 | Upgrade
|
| Net Cash Flow | -624.82 | -46.55 | -1,246 | 3,017 | 1,787 | -259.58 | Upgrade
|
| Free Cash Flow | 160.26 | 138.48 | 125.02 | 34.89 | -1.97 | 671.35 | Upgrade
|
| Free Cash Flow Growth | 46.36% | 10.76% | 258.36% | - | - | 155.91% | Upgrade
|
| Free Cash Flow Margin | 9.60% | 8.26% | 7.14% | 1.92% | -0.09% | 33.64% | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.34 | 0.30 | 0.08 | -0.01 | 1.79 | Upgrade
|
| Cash Income Tax Paid | 159.67 | 177.45 | 182.09 | 211.18 | 198.48 | 227.65 | Upgrade
|
| Levered Free Cash Flow | 70.66 | 52.09 | 46.39 | -182.35 | -228.08 | 461.99 | Upgrade
|
| Unlevered Free Cash Flow | 71.61 | 53.08 | 47.28 | -181.53 | -227.12 | 461.99 | Upgrade
|
| Change in Net Working Capital | -17.13 | 0.9 | -154.89 | 252.88 | 454.96 | 25.24 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.